Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Most recent
Best match
49m
Buy Rating Affirmed for KalVista Pharmaceuticals Amid Strong Phase 3 Data and Market Potential
Debanjana Chatterjee, an analyst from JonesTrading, has initiated a new Buy rating on KalVista Pharmaceuticals (KALV). Debanjana Chatterjee has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Stadiums to serve as shelters
Helene: How to help
Killer gets life sentence
Promotes watch collection
World's oldest cheese found
50/50 ball ownership suit
'Harry Potter' star dies
Urgent safety alert for 737s
Targeted Black residents?
Producing doc on Diddy
Ending password-sharing
More executives leave
Boxes to distribute Narcan
NC board removes 747K
Meta hit with privacy fine
US charges three Iranians
WI duplicate ballot flap
On Secret Service failures
Fake Biden robocalls fine
Troops to leave some bases
Fed inflation gauge cools
Pleads not guilty
High-end brothel plea
ISR targets Hezbollah HQ
ICE: Convicts roaming free
NC dam failure ‘imminent’
Van Gogh paintings attacked
Bill to use birth control
KY sues Express Scripts
Diocese reaches settlement
NY ballot appeal rejected
Deposition in AI suit
Dow closes at record high
Related topics
NVIDIA
S&P 500 Index
Warren Buffett
Dividend
Zacks Rank
Feedback